Creative Medical Technology Holdings, Inc. - CELZ Net earnings per share for the last 12 months

Public company logo of Creative Medical Technology (CELZ)

The success of Creative Medical Technology (CELZ) relies on urology test results and the influx of venture capital. The 12-month EPS growth trend captures this process, where the 41.60 indicator expresses the state of the metric. Patents and interest from pharma behemoths are driving growth, although the fierce competition for leadership in regenerative medicine creates significant risks for the company.

Creative Medical Technology Holdings Inc. - CELZ Net earnings per share (EPS TTM) (period 02/11/2024 - 11/11/2026)

Financial and market metric breakdowns for Creative Medical Technology Holdings Inc. (CELZ)

- market price and analyst price targets:
Market Chart Creative Medical Technology|CELZ - Analyst Consensus Forecast
- issuer market value details:
Market Valuation Creative Medical Technology Holdings, Inc.|CELZ - Total Company Value
- book capitalization data:
Accounting Value of a Share Creative Medical Technology|CELZ - Book Capitalization|Market-to-Book Ratio creativemedicaltechnology.com|CELZ - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Creative Medical Technology|CELZ - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Creative Medical Technology|CELZ - Company Aggregate Debts|Debts to Net Assets Creative Medical Technology Holdings, Inc.|CELZ - Company Long-Term Liabilities|Company Short-Term Debt Creative Medical Technology|Immediate Liquidity creativemedicaltechnology.com
- financial results and valuation multiples details:
CELZ - Net Income|Expected Net Income Creative Medical Technology|CELZ - Price to Earnings Ratio|Projected Price to Earnings Creative Medical Technology|CELZ - PEG Multiple|Company Value to EBITDA Creative Medical Technology Holdings, Inc.|CELZ - Operating profit EBITDA|Earnings per share for the last 12 months Creative Medical Technology|CELZ - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months creativemedicaltechnology.com|CELZ - Earnings growth in current year|Expected earnings per share growth for next year Creative Medical Technology
Fundamental company valuation:CELZ (Creative Medical Technology Holdings)
Mass-produced product of Creative Medical Technology Holdings, Inc.

This indicator measures the dynamics of net earnings per share over a rolling year, excluding seasonal distortions. The calculation is based on comparing the current twelve-month total with the same period from the previous year. By analyzing this chart of relative EPS YoY TTM changes, an investor can see the real efficiency of capitalization. Stable growth confirms the ability of Creative Medical Technology (CELZ) to fund a staff of high-class biologists, which guarantees the continuity of costly developments in the field of regenerative medicine.

Direct competitors

Net earnings per share for the last four quarters mesoblast.com MESO|LCTX: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Surrozen Inc|Earnings per share for the last twelve months Cryo-Cell|FBLG: Earnings per share for the trailing year|Net earnings per share (EPS TTM) LGVN|BRTX - Net earnings per one share for the last twelve months